Association between Prostate Carcinoma and Multiple Myeloma

被引:2
|
作者
Pokhrel, Akriti [1 ]
Heravi, Omid [2 ]
Enayati, Ladan [2 ]
Nelson, Ryan [3 ]
Mooppan, Unni [4 ]
Wu, Richard [5 ]
Wang, Jen C. [2 ]
机构
[1] Brookdale Univ Hosp & Med Ctr, Dept Internal Med, Brooklyn, NY 11212 USA
[2] Brookdale Univ Hosp Med Ctr, Dept Hematol & Oncol, Brooklyn, NY 11212 USA
[3] Brookdale Univ Hosp Med Ctr, Dept Intervent Radiol, Brooklyn, NY 11212 USA
[4] Brookdale Univ Hosp & Med Ctr, Dept Urol, Brooklyn, NY 11212 USA
[5] Brookdale Univ Hosp Med Ctr, Dept Pathol, Brooklyn, NY 11212 USA
关键词
prostate cancer; multiple myeloma; co-occurrence; plasma cell neoplasm; synchronous; ANDROGEN RECEPTOR; GROWTH-FACTOR; CANCER; EXPRESSION; SWEDEN; NEOPLASMS; PATTERNS; PATHWAY; LESIONS;
D O I
10.24976/Discov.Med.202335178.65
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Synchronous or sequential development of multiple myeloma and prostate carcinoma is rare. It is not sure whether these two occur independently or if one influences the development of the other. We reviewed the cases published in the English literature; eight cases of myeloma developing after diagnosis and treatment for prostate carcinoma, five cases of simultaneous occurrence of myeloma and prostate carcinoma, and five cases where the patient with multiple myeloma later developed prostate carcinoma were found. This short review attempts to analyze the occurrence of these two diseases in the same patient and dissect whether there is a close association or it is just a mere coincidence.
引用
收藏
页码:664 / 672
页数:9
相关论文
共 50 条
  • [11] The TOLL of inflammation in multiple myeloma
    Bell, Jessica K.
    CANCER BIOLOGY & THERAPY, 2011, 11 (01) : 68 - 70
  • [12] Association between interleukin gene polymorphisms and multiple myeloma susceptibility
    Shahzad, Muhamaad Naveed
    Ijaz, Iqra
    Naqvi, Syed Shah Zaman Haider
    Yan, Cheng
    Lin, Fanli
    Li, Shutan
    Huang, Chunlan
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (03) : 212 - 224
  • [13] Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer
    Kim, Nae Yu
    Gong, Soo Jung
    Kim, Jimyung
    Youn, Seon Min
    Lee, Jung-Ae
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2011, 31 (04): : 285 - 289
  • [14] Interlink between cholesterol & cell cycle in prostate carcinoma
    Singh, Govind
    Sankanagoudar, Shrimanjunath
    Dogra, Premnath
    Chandra, Nimai Chand
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 146 : 38 - 44
  • [15] Lack of association between TNF-α promoter polymorphisms and multiple myeloma: A meta-analysis
    Li, Bing
    Wang, Xiao-Dan
    Sun, Xiaolei
    Ma, Jianxiong
    Yang, Yang
    Ma, Xinlong
    LEUKEMIA RESEARCH, 2013, 37 (01) : 50 - 57
  • [16] Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma
    Zhou, Xin
    Lu, Yan
    Xia, Jun
    Mao, Jingjue
    Wang, Jing
    Guo, Hongfeng
    CANCER BIOMARKERS, 2021, 32 (01) : 65 - 71
  • [17] Lack of Association Between CD28 Gene Polymorphism and Multiple Myeloma in a Polish Population
    Karabon, Lidia
    Pawlak, Edyta
    Tomkiewicz, Anna
    Kielbinski, Marek
    Potoczek, Stanislaw
    Woszczyk, Dariusz
    Jonkisz, Anna
    Kuliczkowski, Kazimierz
    Frydecka, Irena
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 18 (02): : 129 - 133
  • [18] Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI
    Larbi, A.
    Omoumi, P.
    Pasoglou, V
    Michoux, N.
    Triqueneaux, P.
    Tombal, B.
    Cyteval, C.
    Lecouvet, F. E.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2019, 100 (05) : 295 - 302
  • [19] Prostate carcinoma presenting with diffuse osteolytic metastases and supraclavicular lymphadenopathy mimicking multiple myeloma
    Idowu, Bukunmi Michael
    CLINICAL CASE REPORTS, 2018, 6 (02): : 253 - 257
  • [20] Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma
    Tang, Ju-Xian
    Zhang, Jia-Hui
    Zhou, Ke-Bing
    Li, Wang -Ting
    Wang, Jin-Ying
    Li, Qin
    Yan, Feng-Xia
    Xiao, Duan
    NEOPLASMA, 2022, 69 (05) : 1228 - 1236